# LEQEMBI

NDC: 62856-212
Generic name: lecanemab
Labeler / Manufacturer: Eisai Inc.
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Biologic License Application
Dosage form: INJECTION, SOLUTION
Routes: INTRAVENOUS
Marketing started: 20230106

FDA application: BLA761269

## Active ingredients

- LECANEMAB: 100 mg/mL

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"62856-212"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=62856-212
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=9d1ff786-e577-410a-a273-c4d7d0e4e975